Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection

European Journal of Immunology

Volumn 30, Issue 11, 2000, Pages 3247-3255

  Norrby Teglund, Anna ^a,b   Chatellier, Sonia ^a,c   Low, Donald E ^d   McGeer, Allison ^d   Green, Karen ^d   Kotb, Malak ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c University of TN   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bacterial pathogenesis; Cytokine; Group A streptococcus; Inflammation; Superantigen

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 6; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; INFLAMMATION; MALE; NECROTIZING FASCIITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STREPTOCOCCUS INFECTION;

CYTOKINES; HUMANS; IMMUNITY, NATURAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; VARIATION (GENETICS);

EID: 0033738808     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D     Document Type: Article

References (34)

1. Invasive group A streptococcus infections
2. Group A streptococci in the 1990s
3. Role of superantigens in the pathogenesis of infectious diseases and their sequelae
4. Bacterial pyrogenic exotoxins as superantigens
5. Superantigens and their potential role in human disease
6. Role of superantigens in human diseases
7. Bacterial toxin-induced cytokine production studied at the single-cell level
8. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis
9. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factors
10. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B
11. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates
12. Cytokines and septic shock
13. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock
14. The role of cytokines in infection
15. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration
16. Correlation between serum TNF-α and IL-6 levels and severity of group A streptococcal infections
17. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality
18. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome
19. Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma
20. Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome
21. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis
22. Group A streptococcal bacteremia: The role of tumor necrosis factor in shock and organ failure
23. Shock and tissue injury induced by recombinant human cachectin
24. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
25. A comparison between the effects of interleukin-1α administration and sublethal endotoxemia in primates
26. Activation of coagulation after administration of tumor necrosis factor to normal subjects
27. The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies
28. Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood
29. Genetic relatedness and superantigen expression of M type 1 group A streptococci isolates from severe and non-severe invasive disease
30. Superantigen antagonist protects against lethal shock and defines a new domain for T cell activation
31. Balance of inflammatory cytokines related to severity and mortality of murine sepsis
32. Defining the group A, Working Group on Severe Streptococcal Infections, streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections
33. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991